跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 333 条关于
“ApoE ε4”
全部
333
临床试验
209
药物
33
机构
1
资讯
90
3个月前
Favorable Lifestyle Factors Reduce Dementia Risk Across Key Genetic Profiles, Japanese Study Finds
去年
EMA Recommends Lecanemab for Early Alzheimer's, Limits Use to Specific Genetic Profiles
上个月
APOE-Stratified GWAS Uncovers New Alzheimer's Risk Loci and Supports A Priori APOE Stratification in AD Trials
去年
Gantenerumab's ARIA-E Risk Factors Identified in Alzheimer's Trials
去年
CHMP Recommends Approval of Lecanemab for Early Alzheimer's Treatment in the EU
4个月前
Risen Pharma Initiates Phase 2 Trial of RP902 for Alzheimer's Disease in China
去年
Meta-Analysis Reveals Safety Differences Between Lecanemab and Donanemab in Early Alzheimer's Disease Treatment
去年
EMA Committee Recommends Approval of Lecanemab for Early Alzheimer's Disease
去年
CHMP Recommends Approval of Lecanemab for Early Alzheimer's Disease in the EU
去年
CHMP Recommends Approval of Lecanemab for Early Alzheimer's in the EU
第 1 页,共 9 页
上一页
下一页